Cargando…

An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department

Therapies that halt progression of chronic hepatitis B virus (HBV) and achieve a cure for chronic hepatitis C virus (HCV) have encouraged development of innovative strategies to diagnose and link patients to care. We describe the prevalence and risk factors for HBV and HCV infections and use of an o...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Hannah, Balasegaram, Sooria, Douthwaite, Sam, Hunter, Laura, Kulasegaram, Ranjababu, Wong, Terry, Querol-Rubiera, Antonio, Nebbia, Gaia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059401/
https://www.ncbi.nlm.nih.gov/pubmed/30044779
http://dx.doi.org/10.1371/journal.pone.0198520
_version_ 1783341853398007808
author Evans, Hannah
Balasegaram, Sooria
Douthwaite, Sam
Hunter, Laura
Kulasegaram, Ranjababu
Wong, Terry
Querol-Rubiera, Antonio
Nebbia, Gaia
author_facet Evans, Hannah
Balasegaram, Sooria
Douthwaite, Sam
Hunter, Laura
Kulasegaram, Ranjababu
Wong, Terry
Querol-Rubiera, Antonio
Nebbia, Gaia
author_sort Evans, Hannah
collection PubMed
description Therapies that halt progression of chronic hepatitis B virus (HBV) and achieve a cure for chronic hepatitis C virus (HCV) have encouraged development of innovative strategies to diagnose and link patients to care. We describe the prevalence and risk factors for HBV and HCV infections and use of an opt-out hepatitis testing and integrated linkage to care pathway in a London Emergency Department (ED). ED patients aged ≥16 years having routine blood tests from 15 February-28 March 2016 were tested for hepatitis, unless opted out. Hepatitis B surface antigen (HBsAg) and hepatitis C antibody tests (HCV-Ab, including a confirmatory hepatitis C antigen test (HCV-Ag)) were pre-selected on electronic blood test requests. Linkage to care (attending one clinic appointment) was offered to HBsAg and HCV-Ag patients (new or known-disengaged with care diagnoses). Weighted prevalence estimates and risk factors for seropositivity adjusted by demographics and survey weights were calculated using logistic regression. Hepatitis testing uptake was 56% (3,290/5,865). Overall, 26 HBsAg (10 new diagnoses) and 63 HCV-Ab patients were identified of which 32 were HCV-Ag positive (10 new diagnoses). Weighted seroprevalence of HBsAg was 0.50% (95% CI 0.3–0.8%); HCV-Ab 2.0% (95% CI 1.5–2.7%) and HCV-Ag 1.2% (95% CI 0.8–1.7%). Risk factors for infection were being male (HBsAg: aOR 4.1, 95% CI 1.5–11.3), of non-White British ethnicity (HBsAg: aOR>11) or being homeless (HCV-Ag: aOR 18.9, 95% CI 6.9–51.4). We achieved a high linkage to care uptake for HBsAg (93%) and HCV-Ag (78%) among patients who were contacted and required linkage. A pre-selected hepatitis testing ordering system facilitated a high testing uptake. New and disengaged with care diagnoses and a high HCV prevalence were identified demonstrating the potential to identify and link patients to care in this setting. Strategies connecting clinical care with community outreach services are key for improving patient linkage to care.
format Online
Article
Text
id pubmed-6059401
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60594012018-08-06 An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department Evans, Hannah Balasegaram, Sooria Douthwaite, Sam Hunter, Laura Kulasegaram, Ranjababu Wong, Terry Querol-Rubiera, Antonio Nebbia, Gaia PLoS One Research Article Therapies that halt progression of chronic hepatitis B virus (HBV) and achieve a cure for chronic hepatitis C virus (HCV) have encouraged development of innovative strategies to diagnose and link patients to care. We describe the prevalence and risk factors for HBV and HCV infections and use of an opt-out hepatitis testing and integrated linkage to care pathway in a London Emergency Department (ED). ED patients aged ≥16 years having routine blood tests from 15 February-28 March 2016 were tested for hepatitis, unless opted out. Hepatitis B surface antigen (HBsAg) and hepatitis C antibody tests (HCV-Ab, including a confirmatory hepatitis C antigen test (HCV-Ag)) were pre-selected on electronic blood test requests. Linkage to care (attending one clinic appointment) was offered to HBsAg and HCV-Ag patients (new or known-disengaged with care diagnoses). Weighted prevalence estimates and risk factors for seropositivity adjusted by demographics and survey weights were calculated using logistic regression. Hepatitis testing uptake was 56% (3,290/5,865). Overall, 26 HBsAg (10 new diagnoses) and 63 HCV-Ab patients were identified of which 32 were HCV-Ag positive (10 new diagnoses). Weighted seroprevalence of HBsAg was 0.50% (95% CI 0.3–0.8%); HCV-Ab 2.0% (95% CI 1.5–2.7%) and HCV-Ag 1.2% (95% CI 0.8–1.7%). Risk factors for infection were being male (HBsAg: aOR 4.1, 95% CI 1.5–11.3), of non-White British ethnicity (HBsAg: aOR>11) or being homeless (HCV-Ag: aOR 18.9, 95% CI 6.9–51.4). We achieved a high linkage to care uptake for HBsAg (93%) and HCV-Ag (78%) among patients who were contacted and required linkage. A pre-selected hepatitis testing ordering system facilitated a high testing uptake. New and disengaged with care diagnoses and a high HCV prevalence were identified demonstrating the potential to identify and link patients to care in this setting. Strategies connecting clinical care with community outreach services are key for improving patient linkage to care. Public Library of Science 2018-07-25 /pmc/articles/PMC6059401/ /pubmed/30044779 http://dx.doi.org/10.1371/journal.pone.0198520 Text en © 2018 Evans et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Evans, Hannah
Balasegaram, Sooria
Douthwaite, Sam
Hunter, Laura
Kulasegaram, Ranjababu
Wong, Terry
Querol-Rubiera, Antonio
Nebbia, Gaia
An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department
title An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department
title_full An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department
title_fullStr An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department
title_full_unstemmed An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department
title_short An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department
title_sort innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a london emergency department
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059401/
https://www.ncbi.nlm.nih.gov/pubmed/30044779
http://dx.doi.org/10.1371/journal.pone.0198520
work_keys_str_mv AT evanshannah aninnovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT balasegaramsooria aninnovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT douthwaitesam aninnovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT hunterlaura aninnovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT kulasegaramranjababu aninnovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT wongterry aninnovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT querolrubieraantonio aninnovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT nebbiagaia aninnovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT evanshannah innovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT balasegaramsooria innovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT douthwaitesam innovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT hunterlaura innovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT kulasegaramranjababu innovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT wongterry innovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT querolrubieraantonio innovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment
AT nebbiagaia innovativeapproachtoincreaseviralhepatitisdiagnosesandlinkagetocareusingoptouttestingandanintegratedcarepathwayinalondonemergencydepartment